Tag Archives: Impax Laboratories Inc.

Week’s opening stock roundup: Impax, Omeros shine; Foamix down, but not out

1) Impax Laboratories Inc. (Nasdaq:IPXL) led advancing issues, rocketing $3.40, or 37% over the week, to $12.65. The upward move came after the company reported it has hired Allergan PLC’s… Read more »

Week’s opening stock salvo: Cellect, Impax, Cancer Genetics celebrate; Foamix, not so much

After the resounding thud heard round-the-world Friday upon the failure of Trumpcare, healthcare stocks were back in vogue with investors Monday (March 27, 2017). Here are the top stars and… Read more »

Pharma stocks dive on price-fixing probes; better days for healthcare sector uncertain no matter who’s in the White House

The generic drug industry was jolted last week as shares of many major companies tumbled after a news report said that a federal inquiry into drug price-fixing was wider than… Read more »